Cargando…
Defining sarcopenia and myosteatosis: the necessity for consensus on a technical standard and standardized cut‐off values
Autores principales: | Westenberg, Lisa B., Zorgdrager, Marcel, Viddeleer, Alain R., Pol, Robert A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8977957/ https://www.ncbi.nlm.nih.gov/pubmed/35218312 http://dx.doi.org/10.1002/jcsm.12961 |
Ejemplares similares
-
Reference values for low muscle mass and myosteatosis using tomographic muscle measurements in living kidney donors
por: Westenberg, Lisa B., et al.
Publicado: (2023) -
Are Sarcopenia and Myosteatosis in Elderly Patients with Pelvic Ring Injury Related to Mortality, Physical Functioning and Quality of Life?
por: Banierink, Hester, et al.
Publicado: (2021) -
Prognostic Value of Sarcopenia and Myosteatosis in Patients with Resectable Pancreatic Ductal Adenocarcinoma
por: Kim, Dong Wook, et al.
Publicado: (2022) -
High prevalence of sarcopenia and myosteatosis in patients undergoing hemodialysis
por: Fu, Chen, et al.
Publicado: (2023) -
Psoriasis Is Associated With Myosteatosis but Not Sarcopenia: A Case-Control Study
por: Chen, Xiaomei, et al.
Publicado: (2021)